Lyonization in ophthalmology

Current Opinion in Ophthalmology

Volumn 24, Issue 5, 2013, Pages 389-397

  Wuthisiri, Wadakarn ^a,b   Lingao, Michelle D ^a,c   Capasso, Jenina E ^a   Levin, Alex V ^a,d  

^a WILLS EYE HOSPITAL   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Lyonization; Retinal mosaicism; X inactivation; X linked carrier; X linked ocular disease

Indexed keywords

CHOROIDEREMIA; DARK ADAPTATION; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; EYE DISEASE; EYE EXAMINATION; GENE LOCUS; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; LOWE SYNDROME; NIGHT BLINDNESS; NORRIE DISEASE; OCULOCUTANEOUS ALBINISM; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA MACULA DEGENERATION; RETINITIS PIGMENTOSA; RETINOSCHISIS; REVIEW; SEX CHROMOSOME MOSAICISM; SLIT LAMP; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREORETINOPATHY; X CHROMOSOME INACTIVATION;

EYE DISEASES, HEREDITARY; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, X-LINKED; GENETIC TESTING; HUMANS; MALE;

EID: 84883451555     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283641f91     Document Type: Review

References (131)

1. Lyon M. Gene action in the X-chromosome of the mouse (Mus musculus L). Nature 1961; 190:372-373.
2. Lyon M. X-chromosome inactivation as a system of gene dosage compensation to regulate gene expression. Prog Nucleic Acid Res Mol Biol 1989; 36:119-130.
3. Sofocleous C, Kanioura A, Amenta S, et al. Unravelling X-inactivation through time: Impactions of X-linked disorders in humans. Human Genet Embryol 2012; S3:001.
4. Agrelo R, Wutz A. Context of change: X-inactivation and disease. EMBO Mol Med 2010; 2:6-15.
5. Mlynarczyk-Evans S, Royce-Tolland M, Alexander MK, et al. X-chromosomes alternate between two states prior to random X-Inactivation. PloS Biol 2006; 4:e159.
6. Bacher CP, Guggiari M, Brors B, et al. Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nat Cell Biol 2006; 8:293-299.
7. Lee JT. Homozygous Tsix mutant mice reveal a sex-ratio distortion and revert to random X-inactivation. Nat Genet 2002; 32:195-200.
8. Migeon B. Why females are mosaics: X-inactivation and sex differences in diseases. Gend Med 2007; 4:97-105.
9. Nyhan WL, Bakay B, Connor JD, et al. Hemizygous expression of glucose-6- phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch- Nyhan syndrome. Proc Natl Acad Sci USA 1970; 65:214-218.
10. Orstavik K. X chromosome inactivation in clinical practice. Human Genet 2009; 126:363-373.
11. Minks J, Robinson WP, Brown CJ. A skewed view of X chromosome inactivation. J Clin Invest 2008; 118:20-23.
12. Cattanach BM, Williams CE. Evidence of nonrandom X chromosome activity in the mouse. Genet Res 1972; 19:229-240.
13. Sharp AJ, Stathaki E, Migliavacca E, et al. DNA methylation profiles of human active and inactive X chromosomes. Genome Res 2011; 21:1592-1600.
14. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434:400-404.
15. Wald KJ, Hirose T. Clinical methods for detecting the carrier state of X-chromosome-linked retinal disorders. Int Ophthalmol Clin 1993; 33:203-217.
16. Roberts MF, Fishman GA, Roberts DK, et al. Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia. Br J Ophthalmol 2002; 86:658-662.
17. Sieving PA, Niffenegger JH, Berson EL. Electroretinographic findings in selected pedigrees with choroideremia. Am J Ophthalmol 1986; 101:361-367.
18. Van Den Hurk JA, Schwartz M, van Bokhoven H, et al. Molecular basis of choroideremia (CHM): Mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat 1997; 9:110-117.
19. Cremers FP, Sankila EM, Brunsmann F, et al. Deletions in patients with classical choroideremia vary in size from 45 kb to several megabases. Am J Hum Genet 1990; 47:622-628.
20. Van De Pol TJ, Cremers FP, Brohet RM, et al. Derivation of clones from the choroideremia locus by preparative field inversion gel electrophoresis. Nucleic Acids Res 1990; 18:725-731.
21. Seabra MC, Brown MS, Goldstein JL. Retinal degeneration in choroideremia: Deficiency of rab geranylgeranyl transferase. Science 1993; 259:377-381.
22. Sankila EM, Tolvanen R, van den Hurk JA, et al. Aberrant splicing of the CHM gene is a significant cause of choroideremia. Nat Genet 1992; 1:109-113.
23. Van den Hurk JA, van de Pol TJ, Molloy CM, Brunsmann F, et al. Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. Am J Hum Genet 1992; 50:1195-1202.
24. Van Bokhoven H, Schwartz M, Andreasson S, et al. Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients. Hum Mol Genet 1994; 3:1047-1051.
25. Ponjavic V, Abrahamson M, Andreasson S, et al. Phenotype variations within a choroideremia family lacking the entire CHM gene. Ophthalmic Genet 1995; 16:143-150.
26. Esterman B. Choroideremia; report of a case. Arch Ophthalmol 1947; 37:716-721.
27. MacDonald IM, Russell L, Chan CC. Choroideremia: New findings from ocular pathology and review of recent literature. Surv Ophthalmol 2009; 54:401-407.
28. Jacobson SG, Cideciyan AV, Sumaroka A, et al. Remodeling of the human retina in choroideremia: Rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 2006; 47:4113-4120.
29. Lazow MA, Hood DC, Ramachandran R, et al. Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). Invest Ophthalmol Vis Sci 2011; 52:9581-9590.
30. Mura M, Sereda C, Jablonski MM, et al. Clinical and functional findings in choroideremia due to complete deletion of the CHM gene. Arch Ophthalmol 2007; 125:1107-1113.
31. Cameron JD, Fine BS, Shapiro I. Histopathologic observations in choroideremia with emphasis on vascular changes of the uveal tract. Ophthalmology 1987; 94:187-196.
32. Rodrigues MM, Ballintine EJ, Wiggert BN, et al. Choroideremia: A clinical, electron microscopic, and biochemical report. Ophthalmology 1984; 91:873-883.
33. Ghosh M, McCulloch JC. Pathological findings from two cases of choroideremia. Can J Ophthalmol 1980; 15:147-153.
34. Syed N, Smith JE, John SK, et al. Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. Ophthalmology 2001; 108:711-720.
35. Flannery JG, Bird AC, Farber DB, et al. A histopathologic study of a choroideremia carrier. Invest Ophthalmol Vis Sci 1990; 31:229-236.
36. Cheng CK, Chen MS, Hou PK. Choroideremia: A study of two families. J Formos Med Assoc 1991; 90:1103-1112.
37. Karna J. Choroideremia. A clinical and genetic study of 84 Finnish patients and 126 female carriers. Acta Ophthalmol Suppl 1986; 176:1-68.
38. Thobani A, Anastasakis A, Fishman GA. Microperimetry and OCT findings in female carriers of choroideremia. Ophthalmic Genet 2010; 31:235-239.
39. Vajaranant TS, Fishman GA, Szlyk JP, et al. Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing. Ophthalmology 2008; 115:723-729.
40. Preising MN, Wegscheider E, Friedburg C, et al. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data. Ophthalmology 2009; 116:1201-1209 e.
41. Ohba N, Isashiki Y. Clinical and genetic features of choroideremia. Japanese J Ophthalmol 2000; 44:317.
42. Coussa RG, Kim J, Traboulsi EI. Choroideremia: Effect of age on visual acuity in patients and female carriers. Ophthalmic Genet 2012; 33:66-73.
43. Potter MJ, Wong E, Szabo SM, McTaggart KE. Clinical findings in a carrier of a new mutation in the choroideremia gene. Ophthalmology 2004; 111:1905-1909.
44. Heckenlively Jr. Hereditary retinal and choroidal degenerations. 5th ed Churchill Livingston: Elsevier; 2007.
45. Heckenlively Jr. Retinitis Pigmentosa. JB Lippincott Company; 1988; pp. 6-24.
46. Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet 1980; 32:223-235.
47. Bunker CH, Berson EL, Bromley WC, et al. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol 1984; 97:357-365.
48. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006; 368:1795-1809.
49. Daiger SP. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol 2007; 125:151-158.
50. Meindl A, Dry K, Herrmann K, et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet 1996; 13:35-42.
51. Roepman R, van Duijnhoven G, Rosenberg T, et al. Positional cloning of the gene for X-linked retinitis pigmentosa 3: Homology with the guanine-nucleotide- exchange factor RCC1. Hum Mol Genet 1996; 5:1035-1041.
52. Schwahn U, Lenzner S, Dong J, et al. Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet 1998; 19:327-332.
53. Bhattacharya S, Wright AF, Clayton JF, et al. Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature 1984; 309:253-255.
54. Breuer DK, Yashar BM, Filippova E, et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet 2002; 70:1545-1554.
55. Fishman G. Retinitis pigmentosa. Genetic percentage. Arch Ophthalmol 1978; 96:822-826.
56. Bird AC. X-linked retinitis pigmentosa. Br J Ophthalmol 1975; 59:177-199.
57. Fishman GF, Farber MD, Derlacki DJ. X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol 1986; 1988:369-375.
58. Branham K, Othman M, Brumm M, et al. Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci 2012; 53:8232-8237.
59. Vervoort R, Lennon A, Bird AC, et al. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet 2000; 25:462-466.
60. Sharon D, Sandberg MA, Rabe VW, et al. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet 2003; 73:1131-1146.
61. Pelletier V, Jambou M, Delphin N, et al. Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: Genotype- phenotype correlations and impact on genetic counseling. Hum Mutat 2007; 28:81-91.
62. Mears AJ, Gieser L, Yan D, et al. Protein-truncation mutations in the RP2 gene in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet 1999; 64:897-900.
63. Sharon D, Bruns GA, McGee TL, et al. X-linked retinitis pigmentosa: Mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci 2000; 41:2712-2721.
64. Hardcastle AJ, Thiselton DL, Van Maldergem L, et al. Mutations in the RP2 gene cause disease in 10% of families with familial X-linked retinitis pigmentosa assessed in this study. Am J Hum Genet 1999; 64:1210-1215.
65. Bader I, Brandau O, Achatz H, et al. X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15. Invest Ophthalmol Vis Sci 2003; 44:1458-1463.
66. Ferreira PA. Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms. Hum Mol Genet 2005; 14 Spec No. 2:R259-R267.
67. Neidhardt J, Glaus E, Lorenz B, et al. Identification of novel mutations in Xlinked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis 2008; 14:1081-1093.
68. Mears AJ, Hiriyanna S, Vervoort R, et al. Remapping of the RP15 locus for Xlinked cone-rod degeneration to Xp11.4-p21.1, and identification of a de novo insertion in the RPGR exon ORF15. Am J Hum Genet 2000; 67:1000-1003.
69. Ayyagari R, Demirci FY, Liu J, et al. X-linked recessive atrophic macular degeneration from RPGR mutation. Genomics 2002; 80:166-171.
70. Lorenz B, Andrassi M, Kretschmann U. Phenotype in two families with RP3 associated with RPGR mutations. Ophthalmic Genet 2003; 24:89-101.
71. Sandberg MA, Rosner B, Weigel-DiFranco C, et al. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci 2007; 48:1298-1304.
72. Jayasundera T, Branham KE, Othman M, et al. RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa. Arch Ophthalmol 2010; 128:915-923.
73. Rosenberg T, Schwahn U, Feil S, Berger W. Genotype-phenotype correlation in X-linked retinitis pigmentosa 2 (RP2). Ophthalmic Genet 1999; 20:161-172.
74. Dandekar SS, Ebenezer ND, Grayson C, et al. An atypical phenotype of macular and peripapillary retinal atrophy caused by a mutation in the RP2 gene. Br J Ophthalmol 2004; 88:528-532.
75. Mashima Y, Saga M, Hiida Y, et al. Novel mutation in RP2 gene in two brothers with X-linked retinitis pigmentosa and mtDNA mutation of Leber hereditary optic neuropathy who showed marked differences in clinical severity. Am J Ophthalmol 2000; 130:357-359.
76. Vorster AA, Rebello MT, Coutts N, et al. Arg120stop nonsense mutation in the RP2 gene: Mutational hotspot and germ line mosaicism? Clin Genet 2004; 65:7-10.
77. Wada Y, Nakazawa M, Abe T, Tamai M. A new Leu253Arg mutation in the RP2 gene in a Japanese family with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 2000; 41:290-293.
78. Wu DM, Khanna H, Atmaca-Sonmez P, et al. Long-term follow-up of a family with dominant X-linked retinitis pigmentosa. Eye (Lond) 2010; 24:764-774.
79. Francois J. Chorioretinal degeneration or retinitis pigmentosa of intermediate sex-linked heredity. Doc Ophthalmol 1962; 16:111-127.
80. Goodman G, Ripps H, Siegel IM. Sex-linked ocular disorders: Trait expressivity in males and carrier females. Arch Ophthalmol 1965; 73:387-398.
81. Krill AE. Observations of carriers of X-chromosomal-linked chorioretinal degenerations. Do these support the 'inactivation hypothesis'? Am J Ophthalmol 1967; 64:1029-1040.
82. Klein D, Franceschetti A, Hussels I, et al. X-linked retinitis pigmentosa and linkage studies with the Xg blood-groups. Lancet 1967; 1:974-975.
83. Bird AC, Blach RK. X-linked recessive fundus dystrophies and their carrier states. Trans Ophthalmol Soc U K 1970; 90:127-138.
84. Imaizumi K, Takahashi R, Tazawa Y, et al. Clinical and electrophysiological observations on genetic carriers of retinitis pigmentosa in a family (pedigree Tt) showing sex-linked inheritance. Adv Exp Med Biol 1972; 24:301-307.
85. Berson EL, Rosen JB, Simonoff EA. Electroretinographic testing as an aid in detection of carriers of X-chromosome-linked retinitis pigmentosa. Am J Ophthalmol 1979; 87:460-468.
86. Fishman GA, Weinberg AB, McMahon TT. X-linked recessive retinitis pigmentosa. Clinical characteristics of carriers. Arch Ophthalmol 1986; 104:1329-1335.
87. Vajaranant TS, Seiple W, Szlyk JP, Fishman GA. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology 2002; 109:560-568.
88. Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data. Graefes Arch Clin Exp Ophthalmol 2004; 242:501-511.
89. Churchill JD, Bowne SJ, Sullivan LS, et al. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013; 54:1411-1416.
90. Banin E, Mizrahi-Meissonnier L, Neis R, et al. A nonancestral RPGR missense mutation in families with either recessive or semi-dominant X-linked retinitis pigmentosa. Am J Med Genet A 2007; 143A:1150-1158.
91. Rozet JM, Perrault I, Gigarel N, et al. Dominant X linked retinitis pigmentosa is frequently accounted for by truncating mutations in exon ORF15 of the RPGR gene. J Med Genet 2002; 39:284-285.
92. Al-Maskari A, O'Grady A, Pal B, McKibbin M. Phenotypic progression in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene. Eye (Lond) 2009; 23:519-521.
93. Pomares E, Riera M, Castro-Navarro J, et al. Identification of an intronic single-point mutation in RP2 as the cause of semidominant X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 2009; 50:5107-5114.
94. Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci 1997; 38:1983-1997.
95. Szamier RB, Berson EL. Retinal histopathology of a carrier of X-chromosomelinked retinitis pigmentosa. Ophthalmology 1985; 92:271-278.
96. Aguirre GD, Yashar BM, John SK, et al. Retinal histopathology of an XLRP carrier with a mutation in the RPGR exon ORF15. Exp Eye Res 2002; 75:431-443.
97. Adamian M, Pawlyk BS, Hong DH, Berson EL. Rod and cone opsin mislocalization in an autopsy eye from a carrier of X-linked retinitis pigmentosa with a Gly436Asp mutation in the RPGR gene. Am J Ophthalmol 2006; 142:515-518.
98. Schnur RE, Gao M, Wick PA, et al. OA1 mutations and deletions in X-linked ocular albinism. Am J Hum Genet 1998; 62:800-809.
99. d'Addio M, Pizzigoni A, Bassi MT, et al. Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet 2000; 9:3011-3018.
100. Oetting WS. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene. Hum Mutat 2002; 19:85-92.
101. Spritz RA. Molecular genetics of oculocutaneous albinism. Hum Mol Genet 1994; 3 Spec No:1469-1475.
102. Bassi MT, Schiaffino MV, Renieri A, et al. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet 1995; 10:13-19.
103. O'Donnell FE Jr, King RA, Green WR, Witkop CJ Jr. Autosomal recessively inherited ocular albinism. A new form of ocular albinism affecting females as severely as males. Arch Ophthalmol 1978; 96:1621-1625.
104. Schmitz B, Schaefer T, Krick CM, et al. Configuration of the optic chiasm in humans with albinism as revealed by magnetic resonance imaging. Invest Ophthalmol Vis Sci 2003; 44:16-21.
105. Lauronen L, Jalkanen R, Huttunen J, et al. Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene. Br J Ophthalmol 2005; 89:820-824.
106. Soong F, Levin AV, Westall CA. Comparison of techniques for detecting visually evoked potential asymmetry in albinism. J AAPOS 2000; 4:302-310.
107. Hoffmann MB, Lorenz B, Morland AB, Schmidtborn LC. Misrouting of the optic nerves in albinism: Estimation of the extent with visual evoked potentials. Invest Ophthalmol Vis Sci 2005; 46:3892-3898.
108. Sjostrom A, Kraemer M, Ohlsson J, Villarreal G. Subnormal visual acuity syndromes (SVAS): Albinism in Swedish 12-13-year-old children. Doc Ophthalmol 2001; 103:35-46.
109. Creel D, O'Donnell FE Jr, Witkop CJ Jr. Visual system anomalies in human ocular albinos. Science 1978; 201:931-933.
110. Kriss T, Harris C, Lambert SR. Ocular motility anomalies in developmental misdirection of the optic chiasm. Am J Ophthalmol 1992; 113:601-603.
111. Krill AE, Lee GB. The electroretinogram in albinos and carriers of the ocular albino trait. Arch Ophthalmol 1963; 69:32-38.
112. Russell-Eggitt I, Kriss A, Taylor DS. Albinism in childhood: A flash VEP and ERG study. Br J Ophthalmol 1990; 74:136-140.
113. Rudolph G, Meindl A, Bechmann M, et al. X-linked ocular albinism (Nettleship- Falls): A novel 29-bp deletion in exon 1. Carrier detection by ophthalmic examination and DNA analysis. Graefes Arch Clin Exp Ophthalmol 2001; 239:167-172.
114. O'Donnell FE Jr, Green WR, Fleischman JA, Hambrick GW. X-linked ocular albinism in Blacks. Ocular albinism cum pigmento. Arch Ophthalmol 1978; 96:1189-1192.
115. Lang GE, Rott HD, Pfeiffer RA. X-linked ocular albinism. Characteristic pattern of affection in female carriers. Ophthalmic Paediatr Genet 1990; 11:265-271.
116. Charles SJ,Green JS, Grant JW, et al. Clinical features of affected males with X linked ocular albinism. Br J Ophthalmol 1993; 77:222-227.
117. Falls HF. Sex-linked ocular albinism displaying typical fundus changes in the female heterozygote. Am J Ophthalmol 1951; 34:41-50.
118. Moshiri A, Scholl HP, Canto-Soler MV, Goldberg MF. Morphogenetic model for radial streaking in the fundus of the carrier state of X-linked albinism. JAMA Ophthalmol 2013; 131:691-693.
119. This article proposes that certain morphogenetic movements of RPE precursors during eye development may be the basis of the radial-streaking pattern seen in X-linked ocular albinism carriers
120. Pearce WG, Johnson GJ, Gillan JG. Nystagmus in a female carrier of ocular albinism. J Med Genet 1972; 9:126-129.
121. Wu G, Cotlier E, Brodie S. A carrier state of X-linked juvenile retinoschisis. Ophthalmic Paediatr Genets 1985; 5:13-17.
122. Kim LS, Seiple W, Fishman GA, Szlyk JP. Multifocal ERG findings in carriers of X-linked retinoschisis. Doc Ophthalmol 2007; 114:21-26.
123. Gow J, Oliver GL. Familial exudative vitreoretinopathy. an expanded view. Arch Ophthalmol 1971; 86:150-155.
124. Joos KM, Kimura AE, Vandenburgh K, et al. Ocular findings associated with a Cys39Arg mutation in the Norrie disease gene. Arch Ophthalmol 1994; 112:1574-1579.
125. Shastry BS, Hiraoka M, Trese DC, Trese MT. Norrie disease and exudative vitreoretinopathy in families with affected female carriers. Eur J Ophthalmol 1999; 9:238-242.
126. Lin P, Shankar SP, Duncan J, et al. Retinal vascular abnormalities and dragged maculae in a carrier with a new NDP mutation (c. 268delC) that caused severe Norrie disease in the proband. J AAPOS 2010; 14:93-96.
127. Gardner RJ, Brown N. Lowe's syndrome: Identification of carriers by lens examination. J Med Genet 1976; 13:449-454.
128. Cibis GW, Waeltermann JM, Whitcraft CT, et al. Lenticular opacities in carriers of Lowe's syndrome. Ophthalmology 1986; 93:1041-1045.
129. Lin T, Lewis RA, Nussbaum RL. Molecular confirmation of carriers for Lowe syndrome. Ophthalmology 1999; 106:119-122.
130. Roschinger W, Muntau AC, Rudolph G, et al. Carrier assessment in families with Lowe oculocerebrorenal syndrome: Novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination. Mol Genet Metab 2000; 69:213-222.
131. Loi M. Lowe syndrome. Orphanet J Rare Dis 2006; 1:16.